Immunogenicity and protective efficacy in a rhesus monkey model of vaccine Ac NFUi(S-) MRC against primary type 2 herpes simplex virus infection.
D000818:Animals; D000917:Antibody Formation; D004195:Disease Models, Animal; D005260:Female; D006558:Herpes Genitalis / Q000517:prevention & control; D006561:Herpes Simplex / Q000276:immunology*; D007428:Intradermal Tests; D008253:Macaca mulatta; D008297:Male; D009500:Neutralization Tests; D011234:Precipitins / Q000276:immunology; D018139:Simplexvirus / Q000276:immunology*; D014765:Viral Vaccines / Q000627:therapeutic use*; D014775:Virus Activation
D011234:Precipitins; D014765:Viral Vaccines